REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year 5 months ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year 5 months ago Biophytis annonce sa participation à la BIO International Convention du 16 au 19 juin Biophytis participera à la BIO International Convention du 16 au 19 juin 2025 à Boston, USA, pour présenter ses avancées et son candidat médicament BIO101 Biophytis Biotechnologie Boston BIO International Convention Maladies Liées À L'âge
BRIEF published on 05/30/2025 at 22:05, 1 year 5 months ago Biophytis reporte la publication de ses comptes annuels 2024 Biophytis Assemblée Générale Comptes Annuels Audit Report
BRIEF published on 05/30/2025 at 22:05, 1 year 5 months ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year 5 months ago Information sur les comptes annuels Biophytis reporte la publication des comptes annuels 2024 en raison de complications techniques dans le processus d'audit. L'assemblée générale des actionnaires est également repoussée Biophytis Assemblée Générale Comptes Annuels Audit Report
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year 5 months ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
PRESS RELEASE published on 05/30/2025 at 21:59, 1 year 5 months ago Information sur les comptes annuels Biophytis reporte la publication de ses comptes annuels 2024 en raison de complications techniques dans l'audit. L'assemblée générale est également reportée. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Biophytis Développement Comptes Annuels Report Maladies Liées À L'âge
PRESS RELEASE published on 05/30/2025 at 21:59, 1 year 5 months ago Information on the Annual Financial Statements Biophytis postpones 2024 annual financial statements publication due to technical audit issues, reschedules General Meeting of shareholders following legal procedures Shareholders Financial Statements Biophytis Meeting Audit
BRIEF published on 05/15/2025 at 07:05, 1 year 5 months ago Biophytis Unveils Promising Obesity Treatment at ECO 2025 Biophytis Clinical Trials Obesity Treatment BIO101 ECO 2025
BRIEF published on 05/15/2025 at 07:05, 1 year 5 months ago Biophytis présente une avancée dans le traitement de l'obésité à l'ECO 2025 Biophytis Essai Clinique BIO101 Obésité GLP-1
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:30, 15 minutes ago Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 15 minutes ago SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 15 minutes ago GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 15 minutes ago Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 15 minutes ago q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards
Published on 11/09/2026 at 07:00, 45 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 45 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 45 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 45 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
